言語を選択

HLA-A*0201 | B2M | NY-ESO-1

お問い合わせ

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Bempegaldesleukin	BMS-986321; ONO-7911; NKTR-214	Phase 3 Clinical	Nektar Therapeutics	Coronavirus Disease 2019 (COVID-19); Melanoma; Glioma; Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Neuroblastoma; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Ependymoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Rhabdomyosarcoma; Head and Neck Neoplasms; Leukemia; Medulloblastoma; Solid tumours	詳細
Nanrilkefusp alfa	SO-C101; RLI-15; CYP-0150; SOT-101	Phase 2 Clinical		Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms	詳細
GI-101	SIM-323; SIM323; GI-101	Phase 2 Clinical	GI Innovation Inc	Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis	詳細
Pegenzileukin	THOR-707; SAR-444245	Phase 2 Clinical	Synthorx Inc	Colorectal Neoplasms; Neoplasm Metastasis; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Esophageal adenocarcinoma; Oropharyngeal Neoplasms; Intestinal Neoplasms; Multiple Myeloma; Mesothelioma; Lymphoma, Large B-Cell, Diffuse; Skin Neoplasms; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms	詳細
IPH-6501	IPH-6501; IPH-65	Phase 2 Clinical	Innate Pharma SA	Neoplasms; Lymphoma, Non-Hodgkin	詳細
IAP-0971	IAP-0971	Phase 2 Clinical	SunHo (China) BioPharmaceutical Co Ltd	Solid tumours; Neoplasms; Urinary Bladder Neoplasms	詳細
TransCon IL-2 β/γ		Phase 2 Clinical	Ascendis Pharma A/S	Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung	詳細
MDNA-11	MDNA-11; MDNA11	Phase 2 Clinical	Medicenna Therapeutics Corp	Triple Negative Breast Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Peritoneal Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Skin Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Stomach Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Gastrointestinal Diseases; Carcinoma, Basal Cell; Ovarian Neoplasms; Skin Melanoma	詳細
Simlukafusp alfa	FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP	Phase 1 Clinical	F. Hoffmann-La Roche Ltd	Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma	詳細
BJ-001(Boji Biomedical Technology)	BJ-001	Phase 1 Clinical	Boji Biomedical Technology (Hangzhou) Co Ltd	Solid tumours; Communicable Diseases; Neoplasm Metastasis	詳細
STK-009	STK-009	Phase 1 Clinical	Synthekine Inc	Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lupus Nephritis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell	詳細
FB-102	FB-102; FB102	Phase 1 Clinical	Forte Biosciences Inc	Alopecia Areata; Graft vs Host Disease; Vitiligo; Malabsorption Syndromes	詳細
NL-201 (Neoleukin Therapeutics)	NL-201	Phase 1 Clinical	Neoleukin Therapeutics Inc	Solid tumours	詳細
Recombinant human interleukin 15(Beijing Kawin)		Phase 1 Clinical	Beijing Kawin Technology Share-Holding Co Ltd	Solid tumours	詳細